Home | Publications | Technology place holder
place holder place holder

Technology


Nanomedicine

Innovative Approach in Healthcare Research and Commercial Opportunities

Publication Date   April 2005
Publisher   RNCOS
Product Type   Report
Pages   45
ISBN Number   not applicable
Product Code   RCS002
Ask a question about this product?

Price £395.00

approximately: $738 | €501

Summary


The path-breaking development of nanomedicine technologies is supposed to have an immense effect in providing site-specific therapeutic action with fewer side effects. Nanomedicine, along with techniques that help in early diagnosis of diseases, is bound to provide a big impetus to prophylactic as well as preventive treatment. All these technological advance could mean that treatments are initiated even before the onset of initial symptoms and, in some cases, diseases would be cured or even altogether prevented. With such a huge potential, nanomedicine can very well be the greatest achievement of all-time providing a better quality of life and physical well-being to aone and all.

This research presents an analytical view of the possible therapeutic and diagnostic applications of nanomedicine technology. It also discusses about the developments in nanomedicine around the world, especially the latest researches taking place in this field. And in addition to all that, the research also highlights the technological and business aspects, the regulatory challenges, market drivers and restraints, and the latest research trends.

Content


  • 1. Executive Summary
  • 2. Medicine Today
  • 3. Nanomedicine: An offshoot of Nanotechnology
  • 4. Nanotechnology Segments
    • 4.1 Tools
    • 4.2 Nanomaterials
    • 4.3 Devices
    • 4.4 Intelligent Materials and Machines
  • 5. Nanomedicine Taxonomy
    • 5.1 Biopharmaceutics
      • 5.1.1 Drug Delivery
      • 5.1.2 Drug Discovery
    • 5.2 Implantable Materials
      • 5.2.1 Tissue Repair and Replacement
      • 5.2.2 Structural Implant Materials
    • 5.3 Implantable Devices
      • 5.3.1 Assessment and Treatment Devices
      • 5.3.2 Sensory Aids
    • 5.4 Surgical Aids
      • 5.4.1 Operating Tools
    • 5.5 Diagnostic Tools
      • 5.5.1 Genetic Testing
      • 5.5.2 Imaging
    • 5.6 Nanoscience in Life Sciences
  • 6. Application Of Nanotechnology In Medical Diagnosis
  • 7. Pathways to Nanomedicine
    • 7.1 Nanomedicine: Precursor technologies
      • 7.1.1 Micromachines/MEMS
      • 7.1.2 Telemicrosurgery
      • 7.1.3 Tissue engineering
      • 7.1.4 Molecular manufacturing
  • 8. Nanomedicine: Research Trends and Challenges
    • 8.1 Research Trends in Nanomedicine
      • 8.1.1 Adoption of Nanotechnology by Big Therapeutic and Diagnostic Companies Gives an Impetus to Nanomedicine
      • 8.1.2 Tool Companies Set to Evolve Earlier and Applications To Follow Suit
      • 8.1.3 Lab-to-market Time Estimations Ought to be More Realistic
      • 8.1.4 Nanodiagnostics Slated to Take-off Faster than Other Applications
      • 8.1.5 Nanotechnology-Based Drug Delivery Efforts on the Rise
    • 8.2 Technology Challenges
      • 8.2.1 Scalability Posing a Technological Challenge to Nanomedicine Initiatives
      • 8.2.2 Available Nanomaterials and Component Technologies Need to be Better Harnessed for Nanomedicine Applications
      • 8.2.3 Lack of Appropriate Manufacturing Standards Constrains
    • 8.3 Business and Regulatory Challenges
      • 8.3.1 Cost of Development Could Make Nanomedicine Applications an Expensive Proposition
      • 8.3.2 Shorter Product Life Cycles Could Accost Nanomedicine Applications
    • 8.4 Factors Pushing the Growth of Nano-enabled Drug Discovery
    • 8.5 Restraints to the Growth of Nanomedicine
    • 8.6 Nanomedicine and Nanotechnology Funding
      • 8.6.1 Funding in Nanotechnology--A Global Overview
      • 8.6.2 US Nanotech Bill Provides Nearly $4 Billion for R&D
      • 8.6.3 Nano and MEMS Projects Get Funding from MIT's Deshpande Center
  • 9. Nanotechnology in Drug Delivery and Drug Discovery: Global Developments
    • 9.1 Emerging Developments in Drug Delivery and Drug Discovery
      • 9.1.1 Enabling Formulation and Improving Compound Activity Using NanoCrystal Technology
      • 9.1.2 QDots for High-Content and Initial Drug Screening
      • 9.1.3 LBL-Technology Enables Micro and Nano Encapsulation
      • 9.1.4 Silicone Micro-Needles for Better Transdermal Drug Delivery
  • 10. The Future of Nanomedicine